Cipla expects elevated capital expenditure on automation to continue for three more years
Advertisement
Mumbai: Cipla expects elevated capital expenditure on automation to continue for three more years, a senior official has said. The city-headquartered company started its investment journey on the automation front two years ago and has already been recognised for its work by multiple bodies, Geena Malhotra, the chief technology officer for the company, told PTI recently.
The World Economic Forum (WEF) has recognised one of its four manufacturing units as a 'lighthouse' project for being replicated across the world, Malhotra said, adding that the company will be implementing the same across all of its 42 plants.
"On investments, we have done both regular capital expenditure and also additional investments. We have made a good amount of investments in the last two years and will be investing for about 3-4 years more in this journey," Malhotra said.
The company, however, did not disclose the financial details of its automation spends. The journey on automation has its roots in a decision Cipla took in 2020, where it started with reimagining technology and making it more cost-effective, Malhotra said, adding that it wanted to align closely with the organisation's view of how it sees itself ten years down the line.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.